Pramipexole和左旋多巴在帕金森病初始治疗中的应用—随机对照试验
出处
《美国医学会杂志（中文版）》
2001年第3期107-114,共8页
The Journal of the American Medical Association(Chinese Edition)
参考文献22
-
1Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. Neurology. 1998;50(suppl 3):S1-S57.
-
2Reardon K, Shiff M. Kempster PA. Evolution of motor fluctuations in Parkinson's disease: a longitudinal study over 6 years. Mov Disord. 1999;14:605-611.
-
3Rascol O, Brooks DJ, Korczyn AD,et al.A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole of levodopa. N Engl J Med. 2000;342:1484-1491.
-
4Rinne UK, Bracco F, Chouza C, et al. Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications: results of a double- blind levodopa controlled trial Drugs. 1998;55(suppl 1):23-30.
-
5Piercey MF, Camacho-Ochoa M, Smith MW. Functional roles for dopamine-receptor subtypes. Clin Neuropharmacol. 1995;18(suppl):S34-S42.
-
6Parkinson Study Group. Safety and efficacy of pramipexole in early parkinson disease: a randomized dose-ranging study. JAMA. 1997;278:125-130.
-
7Hubble JP, Koller WC. Cutler NR, et al. Pramipexole in patients with early Parkinson's disease. Clin Neuropharmacol 1995;18:338-347.
-
8Marek KL Dopaminergic dysfunctin in parkinsonism: new lessons from imaging. Neuroscientist. 1999;5:333-339.
-
9Zou L, Jankovic J, Rowe De, Xie W, Appel SH, Le W. Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity. Life Sci 1999;64:1275-1285.
-
10Parkinson Study Group. A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Clin Neuropharmacol 2000;23:34-44.
-
1张深山,叶凯文,高镇松.普拉克索治疗帕金森病伴发抑郁障碍临床疗效与安全性[J].广东医学,2010,31(7):908-910. 被引量：17
-
2方玲,汤义平.普拉克索治疗帕金森病伴发抑郁障碍的对照研究[J].浙江临床医学,2011,13(7):787-789. 被引量：2
-
3徐一峰.抑郁症急性期的初始治疗[J].中华精神科杂志,2013,46(4):233-233.
-
4宋珊珊（编译）.普拉克索缓释片美国获批用于帕金森病[J].中国处方药,2010(3):55-55.
-
5洪霞.失眠：打开认知行为治疗模式[J].大众健康,2016,0(10):32-33.
-
6郭晓蕙.新糖友初始治疗三关键[J].江苏卫生保健（今日保健）,2010(2):18-18.
-
7周婷玉.“新糖友”初始治疗应关注三大“关键词”[J].中国健康月刊,2010(1):58-58.
-
8苏敏,刘春风.多巴胺受体激动剂治疗帕金森病最新进展[J].世界临床药物,2004,25(10):627-630. 被引量：9
-
9曾敏,邹丽萍.咪唑安定治疗难治性癫癎持续状态[J].小儿急救医学,2004,11(2):123-124. 被引量：10
-
10震颤麻痹综合征[J].国外科技资料目录（医药卫生）,2002(1):149-150.
